Register entry
Fresenius Kabi Austria GmbH
- Registered sites
- 2
- Drug products
- 4
- Live patents
- 0
- Countries
- 1
- Base
- Austria
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingActive ingredient (API) manufactureFinished drug manufacturePackagingRepackaging
Sites
Facilities
2| Site | Location | Operations | FEI |
|---|---|---|---|
| Fresenius Kabi Austria | Austria 8055Austria | Analytical testing, Finished drug manufacture, Packaging, Repackaging | 3003708554 |
| Fresenius Kabi Austria GmbH | LinzAustria | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3002807014 |
Catalogue
Marketed products
4Showing 4 of 4.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| Cleviprex | clevidipine | EMULSION | NDA |
| Lactulose | Lactulose | SOLUTION | ANDA |
| - | Lactulose | POWDER | BULK INGREDIENT |
| - | hydroxyprogesterone caproate | INJECTION | DRUG FOR FURTHER PROCESSING |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.